Rainer Porschen

Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group

Dominik Paul Modest, Ingrid Ricard, Volker Heinemann et al. · Annals of Oncology · 2016 · 334 citations · Full text

Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Leucovorin Plus Oxaliplatin in Metastatic Colorectal Cancer: A Final Report of the AIO Colorectal Study Group

Rainer Porschen, Hendrik‐Tobias Arkenau, S. Kubicka et al. · Journal of Clinical Oncology · 2007 · 278 citations · Full text

Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis.

C.‐J. Hsieh, Bodo Klump, Karlheinz Holzmann et al. · PubMed · 1998 · 242 citations

Colectomy Specimens, Genetics, Pathogenesis +15

Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus

Bodo Klump, Chih‐Jen Hsieh, Karlheinz Holzmann et al. · Gastroenterology · 1998 · 186 citations

Esophagus, Esophageal Cancer, Medicine +7

<i>TFAP2E–DKK4</i> and Chemoresistance in Colorectal Cancer

Matthias Ebert, Marc Tänzer, Benjamin Balluff et al. · New England Journal of Medicine · 2012 · 184 citations · Full text